Lysophosphatidic acid (LPA) is the simplest of the glycerol lipids and regulates a number of cellular processes such as morphological changes, migration, proliferation, and inhibition of apoptosis. LPA exerts these effects through activation of the G-protein coupled receptors (GPCRs) LPA1-6 and the intracellular fatty acid receptor peroxisome proliferator-activated receptor-gamma (PPARγ). The overall goal of this thesis was to determine the mechanisms by which LPA enhances cell survival by inhibiting apoptosis. The project was divided into three studies: 1) to determine the mechanism of LPA-mediated inhibition of p53 in A549 lung carcinoma cells, 2) to investigate the regulation of growth plate chondrocytes by LPA, and 3) to determine the mechanisms of LPA-mediated effects in the growth plate. In the first study, evidence is provided that LPA reduces the cellular abundance of the tumor suppressor p53 in A549 lung carcinoma cells. The LPA effect depends upon increased proteasomal degradation of p53 and it results in a corresponding decrease in p53-mediated transcription. The result of LPA-mediated inhibition of p53 in A549 cells is enhanced resistance to chemotherapeutic-induced apoptosis. In the second study, the role of LPA in resting zone chondrocytes (RC cells) was investigated. RC cells are regulated by 24,25-dihydroxyvitamin D3 [24,25(OH)[subscript2]D [subscript 3]] via a phospholipase D-dependent pathway, suggesting downstream phospholipid metabolites are involved. In this study, we showed that 24R,25(OH)[subscript 2]D[subscript 3] stimulates rat costochondral RC cells to release LPA. Additionally, we demonstrated that RC cells respond to LPA with increased proliferation, maturation, and inhibition of apoptosis. In the final study, the mechanism of LPA and 24R,25(OH)[subscript 2]D[subscript 3]-mediated inhibition of chondrocyte apoptosis was further investigated. Our data show that 24R,25(OH)[subscript 2]D[subscript 3] inhibits apoptosis through Ca⁺⁺, PLD, and PLC signaling and through LPA/Gαi/PI[subscript 3]K/mdm2-mediated degradation of p53, resulting in decreased caspase-3 activity. Collectively, our data establish LPA, vitamin D, and p53 as an anti-apoptotic signaling axis.

No description available.

This dissertation describes the elucidation and implementation of derivatisation in the quantification of biologically active vitamin D metabolites in limited volume serum and dry blood spot samples (DBS) using the liquid chromatography tandem-mass spectrometry (LC-MS/MS) analytical technique. This manuscript describes in detail the development and validation of an analytical methodology, highlighting the role derivatisation and mass spectrometry plays in the structural characterisation and quantification of vitamin D metabolites. The first chapter reviews comprehensively, the history of vitamin D biosynthesis discovery as an anti-rickets agent, the biochemistry of vitamin D, its metabolic pathway, functions in the different biological systems and the consequences of its deficiency in the body. The second chapter reviews the current methods and techniques utilised for the detection and characterization of vitamin D metabolites, with specific emphasis based on the contribution made by derivatisation and mass spectrometry. A brief introduction to derivatisation is provided, with specific focus on PTAD and Amplifex diene reagents (Cooksontype reagents) used in this study. The importance of sensitivity and selectivity of targeted analytes is described first in detail for underivatised analytes, followed by PTAD and Amplifex derivatised samples. Chapter 2 also describes the importance of vitamin D quantification using liquid chromatography, the strengths and limitations of LC-MS/MS when used in isolation and after derivatisation. Also discussed, is how combining these techniques can overcome inherent limitations in LCMS/MS and enhance analytical performance. In Chapter 3 the materials and methods used and the study design is laid out, describing a brief introduction of the routinely used clinical diagnostics assay enzyme-linked immunosorbent assay (ELISA) as a reference method and is compared to an LC-MS/MS assay, to ascertain discrepancies and agreement between both methodologies from the same volunteer samples. Chapters 3 and 4 describes the comprehensive development, optimisation and validation of the highly sensitive PTAD derivatives LC-MS/MS assay for the quantification of active vitamin D metabolites, as well as the development of method using Amplifex diene derivatisation. Also discussed, is sample preparation optimisation of DBS and Mitra micro-samples. A holistic approach was taken to the development of the methodologies to provide data from which the required analytical information can be obtained for method evaluation and statistical analysis. The validated PTAD derivatives method is applied to the quantification of vitamin D metabolites in limited volume (100 μL) clinical human serum samples from 30 volunteers compared to results obtained using the clinical diagnostics ELISA technique. In Chapter 4 data analysis is described and the results are further discussed and a conclusion made based on the findings from the study. This study envisaged that combination of limited sample volume and DBS, derivatisation and LCMS/ MS is a powerful tool in vitamin D metabolite analysis and provided evidence of a positive increase in sensitivity and selectivity between derivatised compared to underivatised samples. A 10-fold increase in signal-to-noise-ratio (S/N) was observed when comparing PTAD derivatised, and Amplifex diene derivatised versus underivatised samples. Chapter 5 presents suggested future directions and considerations in the areas of vitamin D metabolite derivatisation and DBS sampling technique analysis using LC-MS/MS research based on the results presented in this dissertation. / Dissertation (MSc)--University of Pretoria, 2017. / Pharmacology / MSc / Unrestricted

Over 200,000 cases of breast cancer are diagnosed every year. Nearly 20% of these patients supplement their diets with some form of vitamin D. This high frequency of vitamin D supplement use may be due in part to research suggesting that cancer patients with higher serum vitamin D3 levels have better prognoses than patients with low serum vitamin D3. However, double-blind clinical trials on the efficacy of vitamin D3 supplementation in breast cancer have been inconclusive. A recent meta-analysis showed evidence of reduced cancer recurrence in patients taking vitamin D3 supplements who had ‘estrogen receptor positive’ (ERα66+) breast cancer, but not those who had estrogen receptor negative’ (ERα66-) breast cancer. Once ingested, vitamin D3 is metabolized in the liver into the circulating pre-hormone 25(OH)D3, which is then further metabolized into 1a,25(OH)2D3 and 24R,25(OH)2D3. 24R,25(OH)2D3 has been shown to activate a number of membrane signaling pathways, some of which overlap with 17b-estradiol (E2) signaling through ERα36, a membrane isoform of ERα66. The central hypothesis of this thesis was that 24R,25(OH)2D3 is tumorigenic in certain cancers and that this tumorigenicity is mediated in part by ERa isoforms. E2 signaling through ERa36 has been described in the ERa66-, ERa36+ breast cancer cell line HCC381. Specific aim 1 determined whether E2 signaling through ERa36 was tumorigenic other cancers with different ERa profiles. Specific aim 2 determined how 24R,25(OH)2D3 affected tumorigenicity in breast cancer using the common breast cancer cell line MCF7 (ERa66+, ERa36+) as a model. Specific aim 3 investigated the role of ERa isoforms in 24R,25(OH)2D3 signaling in breast cancer cell lines by comparing the tumorigenic effects of 24R,25(OH)2D3 in MCF7 cells (ERa66+, ERa36+) and HCC38 cells (ERa66-, ERa36+). To determine whether ERa66 regulates the effects of 24R,25(OH)2D3, ERa66 was expressed in two ERα66- cell lines. The effect of 24R,25(OH)2D3 on apoptosis was assessed in wild-type and ERa-expressing cell lines.

Vitamin-D-Mangel und -Unterversorgung haben sich zu einem großen Problem für die öffentliche Gesundheit entwickelt, das vor allem auf eine unzureichende Sonnenlichtexposition und eine begrenzte Zufuhr dieses essenziellen Nährstoffs über die Nahrung zurückzuführen ist. Diese "Pandemie" hat zu einem bemerkenswerten Anstieg der Nachfrage nach der Bestimmung des zirkulierenden 25-Hydroxyvitamin-D-Spiegels (25(OH)D) geführt. Die meisten Studien fokussieren sich in erster Linie auf 25(OH)D und betrachten es als Biomarker für den Vitamin-D-Status. Es besteht jedoch ein wachsendes Interesse an der gleichzeitigen Messung mehrerer klinisch bedeutsamer Vitamin-D-Metaboliten wie dem nativen Vitamin D, 25(OH)D-Epimeren, 1,25-Dihydroxyvitamin D und 24,25-Dihydroxyvitamin D. Die Flüssigchromatographie/Tandem-Massenspektrometrie (LC-MS/MS) gilt als "Goldstandard" für die Bestimmung des Vitamin-D-Spiegels und ermöglicht die gleichzeitige Analyse mehrerer Analyten, die für das Verständnis der physiologischen Rolle von Vitamin D und seiner klinischen Auswirkungen unerlässlich sind. In der vorliegenden Doktorarbeit soll verschiedene Aspekte der Vitamin-D-Landschaft erforschen, umfassende Einblicke geben und Herausforderungen innerhalb des Forschungsthemas besprechen. Zunächst lag der Schwerpunkt auf dem Vergleich mehrerer Derivatisierungsreagenzien für die Vitamin-D-Analyse und der Frage, wie sie sich auf die Nachweisempfindlichkeit der Methode und die chromatographische Trennung der getesteten Vitamin-D-Metaboliten auswirken. Ein zweiter Schwerpunkt lag auf der Untersuchung der Stabilität der Derivatisierungsprodukte in Serumextrakten. Der letzte Versuch war die Entwicklung einer LC-MS/MS-Methode, die die Ergebnisse der vorangegangenen Untersuchungen nutzen sollte. Als Ergebnis wurde eine neue Methode vorgestellt, die meines Wissens zum ersten Mal FMP-TS für die chemische Derivatisierung von Vitamin-D-Metaboliten verwendet. / Vitamin D deficiency has emerged as a significant public health concern, attributed largely to insufficient exposure to sunlight and limited dietary sources rich in this essential nutrient. This “pandemic” has led to a notable increase in the demand for assessing circulating levels of 25-hydroxyvitamin D (25(OH)D). Most studies have primarily focused on 25(OH)D, considered it as the vitamin D status biomarker. However, there is a growing interest in simultaneously measuring multiple clinically significant vitamin D metabolites such as the native vitamin D, 25(OH)D epimer, 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D and others. Thus, there is an urgent need to develop analytical methods which will be able to separate and quantify the metabolites of interest accurately and precisely. Liquid chromatography/tandem mass spectrometry (LC-MS/MS) stands out as the “gold standard” technique for vitamin D analysis. Its versatility enables simultaneous analysis of multiple analytes, thereby facilitating the generation of comprehensive vitamin D profiles essential for understanding its physiological role and clinical implications. The present doctoral thesis is designed to explore diverse aspects of vitamin D landscape, providing comprehensive insights and addressing challenges within the research topic. Initially there was a focus on comparing multiple derivatization reagents for vitamin D analysis and discovering how they impact the method’s detection sensitivity and the chromatographic separation of the tested vitamin D metabolites. Moreover, there was a second focal point on examining the stability of the derivatization products in serum extracts. The final attempt was the development of an LC-MS/MS method that would utilize the outcomes of the investigations conducted before. As a result, a new method was introduced utilizing FMP-TS for the chemical derivatization of vitamin D metabolites, a reagent which has not been reported before for vitamin D analysis.